After excluding 74 people with positive GAD antibodies (>30 kU/l) (to avoid potential misclassification of autoimmune diabetes as type 2 diabetes) and 92 with non-singleton births, our final analytic cohort included 5982 participants (ESM Fig. 1). This evidence concerns the gene GAD1 and type 2 diabetes mellitus.